Personnel

Tollefson named to board of directors at pharmaceutical firm

Published in Biotech Business Week, April 26th, 2004

Cortex Pharmaceuticals, Inc., (COR) announced that it has appointed Gary D. Tollefson, MD, PhD, to its board of directors.

"Tollefson, a Distinguished Visiting Lilly Research Scholar and Clinical professor of Psychiatry at the Indiana University School of Medicine, brings to Cortex's Board vast experience in neuroscience and significant business accomplishments at Eli Lilly & Company, playing a key strategic role in their blockbuster antidepressant and antipsychotic drugs Prozac and Zyprexia, respectively," stated Roger G. Stoll, chairman, president and CEO of Cortex. The appointment increases the number of directors on the company's Board from six to seven.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2004-04-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry